John Rutka, MO, FRCSC
It appears to me that steroids are a very important eomponent in resolving otie inflammation and infeetion more rapidly. However, the world literature provides eonflieting messages as to their potential toxieity. Some animal studies have indieated that steroids might be toxie to the inner ear.!" On the other hand, Parnes et al have been using high-dose dexamethasone-up to 30 and 40 mg/ mi-in humans for the treatment of Cogan's syndrame and sudden autoimmune sensorineural hearing loss, and their results suggest that steroids are not toxic.'
Steroids probably are not ototoxie. I am eoneerned that they might prevent a perforation from healing, espeeially in an aeute situation. But otherwise, I favor their eoneomitant use with a topieal antibiotie.
I suspeet that steraids pravide an additive effeet, partieularly in patients with signifieant inflammation. For example, granulation tissue ean "hide" baeteria. By redueing the inflammatory response, steroids all ow for greater penetration of the antibiotie. A steraid might also minimize the risk of an allergie OI' irritative reaetion to the antibiotie. In faet , in some studies, steraids alone appeared to be just as effeetive as antibioties in treating aeute external otitis. >?
Steraids might have other advantages, as well , in terms of redueing mueosal edema and thereby improving the delivery of drugs into the middle ear. In a Turkish study of ehranie suppurative otitis media (CSOM), Kaygusuz et al found that the addition of dexamethasone to eiprafloxaein shortened the required treatment eourse from 14 to 7 days ." The addition of dexamethasone also inereased the rates of clinieal response to both ciprofloxaein (from 80 to 90 %) and tobramyein (from 70 to 75 %), although these improvements were not statistieally signifieant. On the other hand, so me studies suggest that steroids do not have any such effeet. Regardless, no study has shown that the addition of a steroid to an antibiotie increases the length of treatment.
With respeet to the differenees among individual steroids in the eal', little has been determined as to whether some are more effeetive than others or if high-poteney steraids are more effeetive than low-poteney agents . In a rat model, Emgard and Hellstrom reeently demonstrated that betamethasone dipropionate alone healed experimentally indueed external otitis more rapidly than did hydroeortisone/oxytetraeyeline, with OI' without polymyxin B. 9
Thomas Oeitmer, MO, PhO I would like to eontinue by reviewing a few other human and animal studies on the effeets of ototopieal steroids in various eapaeities.
Pharmacokinetics. In a study that Dr. Rutka referred to earlier, Parnes et al eondueted a two-part examination of steraid use-one in animals and one in humans.' In an examination of the pharmaeokinetie profiles ofhydroeortisone, methylprednisolone, and dexamethasone in eochlear fluid, they used a guinea pig model to compare three routes of administration-intratympanie, oral, and intravenous. All three steraids aehieved their highest degree of penetration into eochlear fluid via the topieal route. The best profile was seen with methylprednisolone. The authors noted that not only is intratympanie administration more effieaeious, but it also obviates the adverse effeets seen with systemie administration.
Sensorineural hearing loss. Next, Parnes et al admin-
istered either dexamethasone (n = 20) OI' methylprednisolone (n = 17) intratympanieally to 37 humans with sen sorineural hearing loss that had been eaused by various inner eal' diseases. Patients who had had immune-mediated hearing losses experieneed the best response ; notable impravement was also seen in several cases of sudden hearing loss. On the other hand , no benefit oeeurred in patients who had had asudden deterioration of preexisting hearing loss OI' those with eoehlear hydrops. No patient experieneed treatment-induced hearing loss OI' eardrum perforation. Transient treatrnent-related otitis media oeeurred in three patients, but it was contralled with antibiotie therapy. The authors eoncluded that topieal injeetion of steroids appears to be safe and effeetive in eertain diseases. to II years-who had undergone myringotom y and tube place ment for the treatm ent of chronic OI' rec urrent otitis media. Patients received 3 drops of medi cation three times daily for 3 days, beginnin g at the time of tube placement. At the 3-week follow -up, there was no sig nificant differen ce in the rates of PTTO in the two groups. The authors therefor e recommend ed cipr ofloxacin for the prevent ion of PTTO, because its use obviates the risk of ototoxicity without sac rific ing efficacy.
Acute otitis media.
In an anima I experiment, dexameth asone was studied as an adj unct to penicillin G in preventin g mucosal changes during ex per imentally induced acute otitis medi a in 27 rats." After all animaIs we re inoculated with Streptococcus pneumoniae, nine were treated with peni cillin alone, nine rece ived penicillin/dexamethasone, and nine went untrea ted. Compared wit h the co ntroIs, structura l changes were less evident in the two active-treatment groups, but more so in the antibiotic/stero id gro up, partic ularly with respee t to mucosal metaplasia to the secretory epitheli um.
Gelfoam-induced adverse events. In anot her animaI exper iment, hydrocort isone ointment was studied to determ ine if it co uld reduc e the adverse effects of Gelfoam on an abraded middl e ear cav ity-spec ifically, if it could prevent the development of connective tissue ." Twenty rats were divided into two gro ups; the middl e ear mucosa was abraded in 10 rat s and left intact in the other 10. Both groups were furth er subdivided; half of each group had Gelfoam alone inserted into the middl e ear cav ity and the other half rece ived Gelfoam pIus the stero id. At the 8week eva luation, the abraded ears that received the stero id mani fested significantly less Gelfoam-indu ced fibroblastic activity, vascular proliferation, and mild to moderate fibrosis than did the abraded ears that received Gelfoam alone. Likewise, the benefit of the steroid was noted in the intact ears, althoug h not to as grea t an ex tent.
Joseph E. Oohar, MO, MS, FAAP, FACS
At the Children ' s Hospital of Pittsburgh, we co nduc ted a randomized, blinded, placebo-controlled exper iment to assess the efficacy of an antibiotic (tobramycin) and a steroi d (dexa methasone), alone and in co mbi nation, in 60 j uve nile cy nomolgus mon keys with CSOM.14CSOM had been esta blished by crea ting a large perforation in the right ear of eac h anima Iand inoculating it with Pseudomonas aerug inosa. Th e ea rs were allowed to drain for 4 weeks, and then the animaIs were administered one of six types of eardrop (10 mon keys in each group): 0.3% to-6 • Volume 82 • Suppl 2 bramycin alone, 0. 1% dexamethasone alone, low-strength co mbination tobramycin/dexam ethasone (0.3/0 . 1%), hig h-strength tobramycin/dexamethasone ( 1.010.33%), vehiele only, OI' phos phate -buffered saline. Each subject rece ived 3 drops twice daily for 7 weeks.
By the end of treatm ent, all of the antibiotic gro ups had experienced a rapid resolution of otorrhea and eradication of P aeruginosa, but the most effective treatm ents were the two antibiotic /steroi d com binations. In the dexamethaso ne-only grou p, the vehic le group, and the saline group, otorrhea and posi tive cu ltures pers isted. Th e super iority of the antibiotic/steroi d com binations was unequi vocal. An interesting find ing was that although the tobramycinonly group experienced a longer duration of otorrhea than did the combin ation gro ups, no P aeruginosa was present in the disch arge. I believe this represent s co mmo n-se nse ev idence that a co mbination age nt success fully treats both the infectious and the inflammatory components ofCSOM.
We used the same bas ic study desig n to co mpare cipro floxac in/hydrocortisone with ciprofloxacin alone, but we did not find any diffe rence between the two act ive regimens. We spec ulate that the reason for the lack of a difference was ou r use of hydrocortisone, which is less potent than dexamethasone. An interestin g face t of this study co ncerne d the healing of the tympanic mem bra ne. Monkeys have extremely small externa l auditory canals and ear drums. Eve n after a com plete perforation, the drums will often elose, which was problematic duri ng this . study . When elos ures occ urred, we had to reperforate the drum , and when we found steriIe effusion OI' no effusion, we had to reinocul ate the ea r with P aeruginosa. We discovered during this process that the eardr ums that had the highest elosure rates were those that had been treated with either ciprofloxaci n/hydrocortisone OI' ciprofloxacin alone, as opposed to vehicle OI' saline. App roximately 50% of the perforations that were treated with either active age nt had closed. Therefore, we realized that the antibiotic made an obvious co ntribution to the reso lution of both the infectious and infl ammatory proeesses and allowe d the eardrums to heal.
Oiscussion
Dr. Roland: As we've heard in these three presentations, steroids appear to have an additive effect whe n used wit h an antibiotic to treat oto rrhea. By what mec ha nism does this effect occ ur?
Dr. Dohar: Even after anti biotic monotherapy eradicates the pathogen, there is a time lag before the body can reverse the mucosal inflammatory changes . Th e addition of a ste roid expedites the reso lution of the infl amm atory process, which follows a se parate, and in some ways independ ent , time course. We have conducted chinchilla studies to look at cytokin e ex press ion and certain key infl amm atory mediators for otitis med ia. We found that eve n dow n at the moleeul ar level, the addition of a steroi d resu lted in a very dramatie and rapid deerease in the expression of these mediators, rega rdless of whet her we use d a eo neo mita nt antibiotie or not. We fee l fairly eertain from these data that this is the meehanism by whie h steroi ds help.
Dr. Roland: Aeeording to the ava ilable animal data, it also appears that steroi ds ea use little or no ototoxieity. However, the low pH levels of the solutions in whieh they are usually deli vered might lead to so me ototox ieity . For example, aee tie acid is ototox ie. Of eo urse, a stero id eann ot be kept in suspensio n exeept at a fai rly low pH level, say less than 5.5. One reason that tobramye inl dexamethasone is so attraetiv e is that it' sa miero suspension rather than a maerosuspension. It looks like a solutio n but it aetu all y isn 't,
Dr. Conroy: Th at' s true in ge neral. Th ere are so me fo rmulation eha nges that we ea n make that wi ll kee p a stero id a solution. The problem is that these sol utio ns are less stable at higher pH levels. Th e pH levels of eiprofloxaein/hydroeortisone and e iprofloxaei n/dexamet hasone range between 4 and 5. At any pH level beyond 5.5, not only does the steroid beeome less ea pable of remaining in suspension, but the antibiotie does also .
Dr. Rutka: As me ntioned ear lier , Parnes et al used high-dose dexameth asone for the treatm ent of Cogan ' s sy ndro me and post-t rau matie se nsori neura l hearing loss, and it did not ea use any signifiean t harm to the inner ear.'
However, it is difficult to know whethersome of the posttraum a patients would have imp roved spontaneo usly given tim e.
Aneedotall y, approxim ately 40 % of our patients in Toronto who underw ent topieal gentamiein/betamethaso ne ablation for the treatm ent of ineapaeit atin g Meni ere' s disease eontinued to have a small tymp anie membran e perforati on follo wing extrusion of their tubes (see page 9) . On e ea n speeulate that the lon g-term use of the antibiotie/steroid eombinatio n migh t have pre vent ed these ea rdru ms fro m healing by redu eing the inflamm atory response and there by allowi ng the skin edges of the perforation to meet with the mu eosal edges. All of this was on a baekdrop of our use of eoneentrated phenol as the topieal anes thetie durin g tube inser tio n.
Finally, it appears reasonable to conelude that steroi ds sig nifieantly red uee pa in in patients with externa l otitis, espeeially consider ing what we know to be the histopathology in this eondition.
Dr. Roland: Th ere is a meaningful degree of sys te mie absorptio n of top ieal dexameth asone via the middle ear mueosa. Sh ould we be eo neerned about adrenal-pituitary axis suppression?
Dr. Dohar: From an immunosu ppression standpo int, absorption is a noni ssue in adults . Is there any gross suppression in ehildren? Probably not, provided that ther apy is only short term . We have seen so me suppression in ehildren who took long-term inh alational steroids for allergie rhinitis or asthma . But for short-term treatment of ear disease, we shouldn't wo rry beeause the serum steroid levels are quite low.
Dr. Roland: But if it turns out that a ehi ld has taken a steroid-eo nta ining drop for 3 or 4 months, so me adrena l suppression eo uld oee ur. Should we be eoneerned that suc h a drug is on the market ? Prof. Hawke: Th ere isn' t any dr ug on the market that will not ea use dama ge if it' s used improperly. So, no, I' m not worried about the faet that the dru g is avai lable. I' m ju st worried abo ut patient s who abuse medieations beea use they think, " If a little works, a lot must wor k faster. If shor t-term is goo d, long-terin mu st be better. "
Dr. Dohar: Yes, but a patient wo n' t have a 3-mo nth supp ly if a physieian doesn 't write a preseription fo r it. So the physieian ea n prevent this pro blem. Th at ' s not a eo neern fo r me.
Dr. Conroy: Systemie absorption of potent steroi ds is elearly so met hing we sho uld be eo nee rned abou t. The pharmaeokinetie data we 've obtained thus far on eip rofloxaein/dexamethaso ne indieates that there is systemie absorption, but not to the degree that it wou ld ea use eortisol suppression, at least not wi th short-ter m dosingo However, no one knows what would happen if pai n were to pe rsist and the patient were to take the drops for a mueh longer period. It' s always possible that a patient wi ll abuse a dru g, and we eertainly have very litt le eo ntro l over that onee the patient leaves the pharm aey. But we ea n take preeaut ions in form ulating dru gs, whi eh we have don e with eiprofloxaei n/dexa methaso ne. After a 7-day eourse of treatm ent , we would not ex pee t to see anything even elose to eliniea lly relev ant eor tisol suppress ion. Our data sho w that the level of eortiso l suppress ion with topi eal eipro floxaei n/dexamethaso ne is 7-fold lower than that see n with a single 0.5-mg dose of ora l dexamethaso ne. Even if a patie nt took topieal eiprofloxaei n/dexamethasone for a month , eorti sol suppressio n wou ld prob abl y be minimai and quite reversible.
Dr. Roland: Wo uld a nonsteroidal anti-i nflam matory drug (NSAID) be as good as or better than a steroid in eombination with an antibiotie? Should such a prod uet be developed?
Dr. Rutka: I am not awa re of any topieal NSA ID, but oral NSAIDs have been an invaluable adjunet in the managemen t of pain in patients with neerotizing exte rna l oti tis .
Prof. Deitmer: I know fro m perform ing gene ral su rgery that NS AID s are effeetive in diseases that are elose to the skin. Perhaps we should eonsi der using an NSA ID.
Dr. Dohar: In our animal studies of inflamm atory middl e ear disease, we found that steroids do exe rt a very shor t-live d suppress ive effee t on loe al immunity ex pres - sion ; IgA seeretion was the most signifieant. In humans, this is usually not eIinieally signifieant. But there is a small subset of patients in whom it might be signifieant. In these patients, an NSAID would probably be a better option.
Dr . Roland: Are high -poteney steroids more effeetive than low-poteney steroids?
Dr. Dohar: First, I have eome to learn that otolaryngologists' pereeptions of steroid poteney are eompletely different from rheumatologists' pereeptions. They eon sider dexameth asone to be in the same eategory oflow poteney as hydroeortisone. We have the pereeption that there are distinet differenees between the two steroids. Aetually, it' s not j ust a pereeption; it 's baeked up by evidenee from our animai studies.
Second, we ean always achieve whatever degree of anti-inflammatory aetivity we wish by simply adju sting the dosing regimen. For example, we ean inere ase the poteney of dexamethasone by appl ying it direetly to tissue with an otowiek. Beeause the steroid remains in eontaet with the tissue longer, its anti -inflammatory effeets last longer. Our studies of inflammatory markers eonfirm this.
Dr . Roland: You're right. The rank order of steroid poteney in the eye is different from the rank order of poteney in the skin . No one know s what the rank order of poteney in the eal' is. But it' s eertainly true that the switeh from dexamethasone to mometasone, tlutieasone, and triameinolone made a big differenee in nasa l sprays. I realize that eiprofloxaein/de xamethasone is reeommended for short-rather than long-term use, but I'm not so sure that this really is a nonissue.
Dr. Conroy: In well-estabIished ophthalmie model s, corti sone and hydroeortisone-Iike steroids are usually ranked at the bottom of the poteney list and dexamethasone at the top. Mometasone, tlutieasone, and triameinolone are somewhere in the middle. There are many other models we ean use to rank relative poteney, and rankings can vary aeeording to organ system and mode of administration. Depending on what eon straints we put on a model, we ean achieve all kind s of different resuIts . In the mod els that we used for post-tympano stomy tube aeute 8 • Volume 82 • Suppl 2 otiti s medi a with otorrhea and aeute otiti s externa, we found no better steroid than dexamethasone (see page 2).
